FindTrial
Sign In

Analysis of outcome in patients treated with curative intent

Primary Disseminated Multifocal Ewing Sarcoma: Analysis Of Outcome In Patients Treated With Curative Intent

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/10/010234
Enrollment
50
Registered
2017-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C900- Multiple myeloma

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Histologically confirmed ES with histological / radiological diagnosis of metastasis 2.Treatment with curative intent

Exclusion criteria

Exclusion criteria: 1. Isolated lung metastases

Design outcomes

Primary

MeasureTime frame
To determine outcome in terms of Overall Survival (OS)Timepoint: January 2010 to December 2016—

Secondary

MeasureTime frame
1. To determine treatment outcome in terms of Progression free survival (PFS) 2. Determine prognostic factors influencing outcome 3. Determine toxicity profileTimepoint: January 2010 to December 2016—

Countries

India

Contacts

Public ContactDr Nehal R Khanna

Tata Memorial Hospital

nehal.khanna@gmail.com9869266986

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026